Mutual Fund Ownership
Ownership as on: Wed, 6 Nov, 2024

Quant Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)26.03
% of AUM5.74%

Quant Business Cycle Fund Regular Growth

NA
Equity
Amount Invested (Cr.)41.89
% of AUM2.54%

Old Bridge Focused Equity Fund Regular Growth

NA
Equity
Amount Invested (Cr.)17.85
% of AUM2.21%

Navi Aggressive Hybrid Fund Regular Growth

2/5
Hybrid
Amount Invested (Cr.)2.13
% of AUM1.88%

Union Innovation & Opportunities Fund Regular Growth

NA
Global Fund of Funds
Amount Invested (Cr.)13.83
% of AUM1.61%

FAQs about Glenmark Life Sciences share price

Glenmark Life Sciences is trading at 1099.00 as on Wed Nov 06 2024 09:59:51. This is 3.64% upper as compared to its previous closing price of 1060.45.

The market capitalization of Glenmark Life Sciences is 13012.38 Cr as on Wed Nov 06 2024 09:59:51.

The average broker rating on Glenmark Life Sciences is Strong Buy. The breakup of analyst rating is given below -

  • 3 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Glenmark Life Sciences is 1335.00 whereas the 52 wk low is 610.05

Glenmark Life Sciences can be analyzed on the following key metrics -

  • TTM P/E: 30.60
  • Sector P/E: 33.80
  • Dividend Yield: 2.12%
  • D/E ratio: 0.01

Glenmark Life Sciences reported a net profit of 470.89 Cr in 2024.

Recommended For You
Trending Stocks
1,824.30+70.50(4.02%)
1,696.00+62.80(3.85%)
3,177.50-55.55 (-1.72%)
1,077.60-12.40 (-1.14%)
HomeMarketsPremiumInstant LoanMint Shorts